🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Addressing excess weight early helps achieve early glycemic control and is associated with reducing long-term risks.¹⁻³ Early intensive glycemic control (HbA1c <7%) makes a lasting difference for patients with T2D. ²,³ 👉 Follow us for more insights.

#DiabetesCare requires a multifactorial and holistic approach that goes beyond simply meeting HbA1c targets.¹,² Don’t miss out on more insights—follow us!

Discover the 4 key components of holistic care that the ADA/EASD consensus report emphasizes as the Goals of #DiabetesCare.¹ Follow us for more insights!

The ADA/EASD consensus report 5S’s of daily physical activity can be key to effective #DiabetesCare.¹ A focus on exercise, activity, and reducing sedentary time is important for management of T2D.¹ Follow us for more insights!

Effective #DiabetesCare goes beyond one-size-fits-all solutions. A holistic, patient-centered approach to T2D involves regular assessments to adapt care and manage risk factors early.¹ Follow us for more insights.

Proactive #DiabetesCare can help prevent complications and ensure better, healthier futures.¹⁻³ Stay tuned for more valuable insights!

Is focusing on HbA1c targets enough in #Type2Diabetes (T2D) management? #T2D is a complex, chronic, heterogeneous disease that develops through diverse pathophysiological and molecular mechanisms.¹,² Follow us for more!

Type 2 diabetes (T2D) is a complex disease characterized by its diversity and influenced by risk factors that can be either modifiable or inherent.¹,² How can we better address the challenges of managing T2D? Follow us for more insights on #DiabetesCare.

#Type2diabetes is a very heterogeneous disease with variable age at onset, related degree of obesity, insulin resistance and tendency to develop complications. How can #DiabetesCare be tailored to respect and address these differences? Stay tuned and follow us for more!

Early, intensive glycemic control presents patients with the best opportunity to reduce the risk of microvascular complications. The ADA/EASD recommendations highlight the strategies to prevent these risks—check out the details in the image. Follow for more!

Early and intensive glycemic control (HbA1c <7%/53 mmol/mol) can help prevent complications associated with type 2 diabetes (T2D). How do you discuss HbA1c goals with your patients with #T2D? Join the conversation and follow us for more!

The UKPDS study found that early and tight glycemic control had a more significant impact on clinical outcomes than delayed glycemic control in patients with #Type2Diabetes. Follow our account for more insights!

What is therapeutic inertia in #Type2Diabetes? According to the ADA/EASD consensus, it occurs when goals or targets are not met, and diabetes management strategies are not adapted.¹ How to address and reduce the burden of therapeutic inertia in #Diabetes? Follow for more!

Could tighter HbA1c targets benefit some patients with #Type2Diabetes? Aiming for a lower HbA1c level than <7% may have value when it can be achieved without a large risk of hypoglycemia. Follow us for more!

Early detection of #Type2Diabetes and intensive glucose control from diagnosis can maximize reduction of the long-term risk of glycemic complications. But what factors influence the outcomes of early hyperglycemia? Follow us for more insights!

How do you approach personalizing HbA1c targets for patients with #Type2Diabetes? The ADA/EASD consensus recommends personalizing glycemic targets based on each individual's preferences and characteristics. Follow for more!

Despite many advances in #T2D, we strive for new approaches to improve and transform care. Follow us for more insights!

Globally, an estimated up to 45% of people with #Diabetes remain undiagnosed. At Lilly, we’re committed to raising awareness and supporting better access to care. Follow us for more insights!

#DiabetesCare requires a multifactorial and holistic approach that goes beyond simply meeting HbA1c targets.¹,² Don’t miss out on more insights—follow us!

#T2D management should extend beyond just meeting HbA1c targets. This approach is due to the Egregious Eleven — the 11 key factors that cause hyperglycemia, which require multifactorial and holistic care.¹,² Follow us for more perspectives on #Diabetes